Keyphrases
Beta-blockers
100%
Neurohormone
100%
Acute Decompensated Heart Failure
100%
Beta-blocker Therapy
100%
Failure Effects
100%
ACE Inhibitors
50%
Beta-blockade
50%
Plasma Renin Activity
33%
Clinical Characteristics
16%
Clinical Trials
16%
Beneficial Effects
16%
Moderate to Severe
16%
Group Size
16%
Plasma Samples
16%
Retrospective Analysis
16%
Neurohormonal
16%
Statistical Significance
16%
Chronic Heart Failure
16%
Patients with Chronic Heart Failure
16%
ACE Inhibition
16%
Severe Chronic Heart Failure
16%
Plasma Aldosterone Concentration
16%
Endothelin-1 (ET-1)
16%
Reduced Mortality
16%
Plasma Endothelin
16%
Nursing and Health Professions
Heart Failure
100%
Neurohormone
100%
Beta Adrenergic Receptor Blocking Agent
100%
Dipeptidyl Carboxypeptidase Inhibitor
37%
Beta Adrenergic Receptor Blocking
37%
Plasma Renin Activity
25%
Aldosterone Blood Level
12%
Endothelin
12%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Beta Adrenergic Receptor Blocking Agent
100%
Neurohormone
100%
Dipeptidyl Carboxypeptidase Inhibitor
37%
Renin
25%
Clinical Trial
12%
Aldosterone
12%
Endothelin
12%